Therapeutics News and Research

RSS
Researchers find SNARE-like protein system to help bacteria avoid cell destruction

Researchers find SNARE-like protein system to help bacteria avoid cell destruction

RXi Pharmaceuticals presents new preclinical data from its advanced RNAi therapeutic platform

RXi Pharmaceuticals presents new preclinical data from its advanced RNAi therapeutic platform

New York Governor participates in roundtable discussion on stem cell research

New York Governor participates in roundtable discussion on stem cell research

Hospira and Celltrion agree to develop and market eight biogeneric products

Hospira and Celltrion agree to develop and market eight biogeneric products

Lpath reports positive Phase 1 clinical trial results of iSONEP in wet-AMD patients

Lpath reports positive Phase 1 clinical trial results of iSONEP in wet-AMD patients

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

Roche scientist honored with 2009 Meienhofer Award for excellence in peptide chemistry

Roche scientist honored with 2009 Meienhofer Award for excellence in peptide chemistry

Halozyme Therapeutics to host a meeting for analysts and investors

Halozyme Therapeutics to host a meeting for analysts and investors

Ipsen and Spirogen sign new licensing agreement for development of SJG-136 anticancer agent

Ipsen and Spirogen sign new licensing agreement for development of SJG-136 anticancer agent

Kylin Therapeutics receives notice of allowance for its first U.S. patent application

Kylin Therapeutics receives notice of allowance for its first U.S. patent application

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

NCI awards BioMarker Strategies a SBIR contract to develop its SnapPath live-tumor-cell testing system

NCI awards BioMarker Strategies a SBIR contract to develop its SnapPath live-tumor-cell testing system

Zelos Therapeutics commences patient dosing of ZT-034 for treating osteoporosis

Zelos Therapeutics commences patient dosing of ZT-034 for treating osteoporosis

Aryx Therapeutics to raise up to $35 million from sale of its common stock

Aryx Therapeutics to raise up to $35 million from sale of its common stock

Allos Therapeutics to raise $99.4 million through sale of its common stock

Allos Therapeutics to raise $99.4 million through sale of its common stock

Panel Intelligence expands patient focused market research service

Panel Intelligence expands patient focused market research service

Scientists develop new molecule that can deliver genetic-based drugs into cells

Scientists develop new molecule that can deliver genetic-based drugs into cells

Fully validated assay to detect the presence of Calicivirus 2117 in biological samples

Fully validated assay to detect the presence of Calicivirus 2117 in biological samples

Repros announces results of its Androxal efficacy study for secondary hypogonadism

Repros announces results of its Androxal efficacy study for secondary hypogonadism

Vantia Therapeutics announces the start of Phase II proof-of-concept trials of its VA111913 drug

Vantia Therapeutics announces the start of Phase II proof-of-concept trials of its VA111913 drug